Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43)
The summary for the Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43): This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic or skin diseases. Rare diseases have a prevalence of fewer than 200,000 affected individuals in the United States. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic or skin diseases. See the NIAMS Long-Range Plan for more information about NIAMS research interests (http://www.niams.nih.gov/About_Us/Mission_and_Purpose/long_range.asp).
Federal Grant Title: | Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AR-12-006 |
Type of Funding: | Grant |
CFDA Numbers: | 93.846 |
CFDA Descriptions: | Arthritis, Musculoskeletal and Skin Diseases Research |
Current Application Deadline: | Oct 11, 2011 |
Original Application Deadline: | Oct 11, 2011 |
Posted Date: | Jun 10, 2011 |
Creation Date: | Jun 10, 2011 |
Archive Date: | Nov 11, 2011 |
Total Program Funding: | $1,500,000 |
Maximum Federal Grant Award: | $300,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...
- • Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...
- • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...
- • Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
- • NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
- • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
- • Niams Small Grant Program for New Investigators
- • Skin Diseases Research Core Centers
- More Grants from the National Institutes of Health
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
- • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...